Microbiota of the intestine | Probiotics

Encyclopedia of Human Nutrition

Volumn , Issue , 2005, Pages 244-251

  Gueimonde, M ^a   Salminen, S ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882536367     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-12-226694-3/02237-7     Document Type: Chapter

References (25)

1. Benno Y., Mitsuoka T. Development of intestinal microflora in humans and animals. Bifidobacteria Microflora 1986, 5:13-25.
2. Dai D., Walker W.A. Protective nutrients and bacterial colonization in the immature human gut. Advances in Pediatrics 1999, 46:353-382.
3. De Roos N., Katan M. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. American Journal of Clinical Nutrition 2000, 71:405-411.
4. Falk P.G., Hooper L.V., Midvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology. Microbiology and Molecular Biology Reviews 1998, 62:1157-1170.
5. Guandalini S., Pensabene L., Zikri M., Dias J., Casali L., Hoekstra H., Kolacek S., Massar K., Micetic-Turk D., et al. Lactobacillus GG administered in an oral rehydration solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatric Gastroenterology and Nutrition 2000, 30:54-60.
6. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003, 381:512-519.
7. Gueimonde M., Ouwehand A.C., Salminen S. Safety of probiotics. Scandinavian Journal of Nutrition 2004, 48:42-48.
8. He F., Morita H., Hashimoto H., Hosoda M., Kurisaki J., Ouwehand A.C., Isolauri E., Benno Y., Salminen S. Intestinal Bifidobacterium species induce varying cytokine production. Journal of Allergy and Clinical Immunology 2002, 109:1035-1036.
9. Isolauri E., Kirjavainen P.V., Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation?. Gut 2002, 50(Suppl. 3):iii54-iii59.
10. Isolauri E., Salminen S., Ouwehand A.C. Probiotics. Best Practice and Research Clinical Gastroenterology 2004, 18:299-313.
11. Jonkers D., Stockbrügger R. Probiotics and inflammatory bowel disease. Journal of the Royal Society of Medicine 2003, 96:167-171.
12. Kalliomäki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. Journal of Allergy and Clinical Immunology 2001, 107:129-134.
13. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in the prevention of atopic diseases: a randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
14. Ohashi Y., Nakai S., Tsukamoto T., Masumori N., Akaza H., Miyanaga N., et al. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urology International 2002, 68:273-280.
15. Pridmore R.D., Berger B., Desiere F., Vilanova D., Barretto C., Pittet A.-C., Zwahlen M.-C., Rouvet M., Altermann E., Barrangou R., Mollet B., Mercenier A., Klaenhammer T., Arigoni F., Schell M.A. The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2512-2517.
16. Salminen S., Bouley M.C., Boutron-Rualt M.C., Cummings J., Franck A., Gibson G., Isolauri E., Moreau M.-C., Roberfroid M., Rowland I. Functional food science and gastrointestinal physiology and function. British Journal of Nutrition 1998, 147-171. Suppl 1:.
17. Salminen S.J., von Wright A.J., Ouwehand A.C., Holzapfel W.H. Safety assessment of probiotics and starters. Fermentation and Food Safety 2001, 239-251. Aspen Publishers, Inc., Gaithersburg. 1st edn. M.R. Adams, M.J.R. Nout (Eds.).
18. Schell M.A., Karmirantzou M., Snel B., Vilanova D., Berger B., Pessi G., Zwahlen M.-C., Desiere F., Bork P., et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:14422-14427.
19. Schiffrin E.J., Brassart D., Servin A.L., Rochat F., Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. American Journal of Clinical Nutrition 1997, 66:515S-520S.
20. Shanahan F. Crohn's disease. Lancet 2002, 359:62-69.
21. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. Journal of Immunology 1997, 159:1739-1745.
22. Tannock G.W. Probiotics: time for a dose of realism. Current Issues in Intestinal Microbiology 2003, 4:33-42.
23. Van Niel C.W., Fewudtner C., Garrison M.M., Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002, 109:678-684.
24. Vaughan E., de Vries M., Zoentendal E., Ben-Amor K., Akkermans A., de Vos W. The intestinal LABs. Antonie Van Leeuwenhoek 2002, 82:341-352.
25. Xu J., Chiang H.C., Bjursell M.K., Gordon J.I. Message from a human gut symbiont: sensitivity is a prerequisite for sharing. Trends in Microbiology 2004, 12:21-28.